Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin DE000BAY0017
Ticker BAYN.DE
Company BAYER
Currency
Price
Aware Investor Index (AII) 0.8192
Recommendation BUY
P/E 25.04
ROE 11.92 %
Capitalization 65,405,774,253 $
Dividend Yield 4.33 %
P/S 1.61
AII Position 298
P/E Position 377
ROE Position 306
Capitalization Position 128
Dividend Yield Position 151
Sales 35,015,000,000 €
10-Year Average Earnings 2,250,400,000 €
Shares Outstanding 872,107,808
Equity 18,875,000,000 €
Dividend per Share 2.8 €
Industry Pharmaceutical
Country Germany
BAYER Investor Relations Web Site http://www.investor.bayer.com/en/







Sales:

YEAR MONTH AMOUNT
2017 12 35,015,000,000.00 €
2016 12 34,943,000,000.00 €
2015 12 46,324,000,000.00 €
2014 12 42,239,000,000.00 €
2013 12 40,157,000,000.00 €
2012 12 39,760,000,000.00 €
2011 12 36,528,000,000.00 €
2010 12 35,088,000,000.00 €
2009 12 31,168,000,000.00 €
2008 12 32,918,000,000.00 €

Earnings:

YEAR MONTH AMOUNT
2017 12 2,900,000,000.00 €
2016 12 2,233,000,000.00 €
2015 12 4,110,000,000.00 €
2014 12 3,426,000,000.00 €
2013 12 3,189,000,000.00 €
2012 12 889,000,000.00 €
2011 12 1,125,000,000.00 €
2010 12 1,245,000,000.00 €
2009 12 2,226,000,000.00 €
2008 12 1,161,000,000.00 €

Equity:

YEAR MONTH AMOUNT
2017 12 18,875,000,000.00 €
2016 12 16,565,000,000.00 €
2015 12 24,265,000,000.00 €
2014 12 20,106,000,000.00 €
2013 12 13,888,000,000.00 €
2012 12 14,363,000,000.00 €
2011 12 13,888,000,000.00 €

Shares Outstanding:

YEAR MONTH AMOUNT
2017 12 872,107,808
2016 12 832,502,808
2015 12 826,947,808
2014 12 826,947,808
2013 12 826,947,808
2012 12 826,947,808
2011 12 826,950,000

 












Bloomberg News for BAYER:



Google News for BAYER:

The Pharma Letter - 8 hours ago
Bayer to sell Animal Health unit to Elanco for $7.6 billion
German life scienes group Bayer (BAYN: DE) has offloaded its Animal Health business. The unit is to be bought by US animal health company ...
The Pharma Letter - 1 day ago
Indian High Court rules against Bayer on Nexavar and Xarelto API ...
Indian High Court rules against Bayer on Nexavar and Xarelto API ... in German pharma major Bayer's (BAYN: DE) cancer drug Nexavar, and ...
Yahoo Finance - 30 Jul 2019
Edited Transcript of BAYN.DE earnings conference call or ...
Q2 2019 Bayer AG Earnings Call. Leverkusen Aug 1, 2019 (Thomson StreetEvents) -- Edited Transcript of Bayer AG earnings conference call ...
The Pharma Letter - 9 Aug 2019
Bayer flip flops amid Roundup settlement claims
A report claiming that Bayer (BAYN: DE) was proposing a multi-billion dollar settlement of its US lawsuits over the alleged-cancer causing ...
The Pharma Letter - 30 Jul 2019
Pharma sales bring rare cheer as markets batter Bayer again
Pharma sales bring rare cheer as markets batter Bayer again ... quarterly financial results at German life sciences group Bayer (BAYN: DE).
The Pharma Letter - 8 Aug 2019
Bayer pushes further into cell therapy buying out JV BlueRock
German pharma and crop sciences major Bayer (BAYN: DE) has entered into an agreement to fully acquire BlueRock Therapeutics, a privately ...
The Pharma Letter - 23 Jul 2019
Bayer initiates voluntary Kogenate recall due to mislabeling
Germany's Bayer (BAYN: DE) is voluntarily recalling two lots of Kogenate FS antihemophilic factor (recombinant) 2000 IU vials in the USA to the ...
FXStreet - 4 days ago
Session quiet but markets remain focused on global yields
Healthcare: Bayer [BAYN.DE] +2% (analyst action). - Industrials: Pendragon [PDG.UK] +2.5% (divestment). - Technology: AMS [AMS.CH] +3% ...
FXStreet - 8 Aug 2019
Welcome respite to recent volatility in session helps spark a relief rally
Healthcare: Siemens Healthineers [SHL.DE] -0.5% (acquisition), Merck KGaA [MRK.DE] +2% (earnings), Bayer [BAYN.DE] % (agreement with ...
The Pharma Letter - 1 Aug 2019
Positive reimbursement decision for Xarelto in the UK
German pharma major Bayer (BAYN: DE) is set to receive a positive reimbursement decision from the UK's National Institute for Health and ...


Back